Additional blinded screening of the 51 cases and 53 controls at the Robert Koch Institute using an ELISA employing recombinant Gag and Env XMRV proteins identified weak seroreactivity in one CFS case and a healthy control, which was not
confirmed by immunofluorescence.
Not exact matches
The Western blotting results were further
confirmed by in situ
immunofluorescence staining.
In order to further
confirm the results of Western blotting, the expression of p53 was further examined
by immunofluorescence staining.
By immunofluorescence microscopy, Thy1 - PE - labeled CD3ε + cells were observed in the SCS and in nearby lymphatic sinuses, and few labeled cells were detected within the LN parenchyma,
confirming that footpad injection of PE - conjugated antibody led to preferential labeling of lymph - exposed LN cells (Figure 3E).